Evaluation of Sentinel Lymph Node Biopsy Outcomes in Colon Cancer and Anthropometrics

Overview

Sentinel lymph node biopsy (SLNB) in colon cancer (CC) was assessed in 103 patients to evaluate its efficacy relative to patient anthropometric features including BMI and body composition indices. The study found that SLNB detection rates and accuracy may be influenced by body composition, highlighting the importance of considering intra-abdominal obesity in patient selection.

Background

Lymph node metastasis is the most critical prognostic factor in colorectal cancer, significantly reducing 5-year survival rates. Accurate lymph node staging guides adjuvant therapy decisions, which improve survival. SLNB allows targeted examination of the first draining lymph nodes, potentially improving detection of micrometastases beyond standard H&E staining. However, intra-abdominal obesity may hinder SLNB efficacy by complicating lymph node identification, necessitating evaluation of anthropometric factors influencing procedure success.

Data Highlights

Key Findings

• SLNB was performed successfully in 103 colon cancer patients with standardized technique using Patent Blue dye.
• Anthropometric measures including BMI and derived indices were calculated to assess their impact on SLNB outcomes.
• Intra-abdominal obesity, as estimated by body composition indices, may reduce SLNB detection rates and increase false negatives.
• SLNB allows detection of micrometastases by immunohistochemical staining, potentially upstaging lymph node status beyond H&E results.
• Patient selection for SLNB should consider anthropometric factors to optimize diagnostic accuracy and therapeutic decision-making.

Clinical Implications

Clinicians should consider patient anthropometric characteristics such as BMI and body composition when planning SLNB in colon cancer, as increased intra-abdominal adiposity may impair lymph node identification and biopsy accuracy. Tailoring patient selection based on these measurable parameters could improve staging precision and guide appropriate adjuvant therapy. Additionally, awareness of these factors is important when interpreting SLNB results to avoid false negatives.

Conclusion

SLNB in colon cancer is a valuable diagnostic tool whose efficacy may be influenced by patient anthropometrics and body composition. Incorporating these assessments into clinical practice can enhance patient selection and improve staging accuracy.

References

1. Multiple sources [1–27] -- Evaluation of Sentinel Lymph Node Biopsy Outcomes in Colon Cancer